Zoekresultaten - 6 results
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
Arbyn Source: Virol J, Volume 20, Issue 1 (2023) Keywords: Clinical Laboratory Techniques COVID-19 COVID-19 Testing Humans Molecular Diagnostic Techniques Pandemics SARS-CoV-2 Sensitivity and Specificity ...
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
existing medical services and cytopathology laboratories in Alsace. Cytological and histological data were completed with data from the two cancer registries covering the region (Bas-Rhin and Haut-Rhin). ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
intra- and inter-laboratory agreement regarding detection of high-risk HPV DNA exceeding 87% with kappa ≥0.5. RESULTS The Xpert HPV assay showed high intra-laboratory reproducibility with an overall ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
particular devices before collection of a cervical sample by a clinician. Sample sets are subsequently analysed in a laboratory accredited for HPV testing. Disease verification for all enrolled patients is ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
cytology registry was set up in collaboration with local cytopathological laboratories, provincial health authorities and the Limburg Cancer Registry. Laboratories regularly communicated coded results of Pap ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
Proportions of abnormal cytology results varies widely between laboratories. It is unlikely that the introduction of HPV screening would lead to a large increase in confirmation tests in the Belgian context. ...